Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04470232
Other study ID # 20_RIPH3-03
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 11, 2020
Est. completion date March 2023

Study information

Verified date December 2021
Source University Hospital Center of Martinique
Contact Mathieu SEVERYNS, MD
Phone 05 96 55 22 21
Email mathieu.severyns@chu-martinique.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The management of coxofemoral pathologies is constantly increasing. In addition to degenerative hip pathology, the orthopedic surgeon is now confronted with pathologies such as femoro-acetabular conflict, pathologies of the gluteus medius and pathologies of the labrum whose early management limits arthritis degeneration. These pathologies are mainly encountered in young subjects (<60 years). Self-questionnaires play an important role in understanding patients' point of view on the impact of their coxofemoral pathologies and also allow an assessment of their condition after treatment. For the evaluation of coxofemoral pathologies in the young subject (<60 years) the Super Simple Hip score (SUSHI-score) was developed and validated. In the elderly subject with hip osteoarthritis, the HOOS score has the advantage of specifically measuring pain, symptoms, function and quality of life, but is made up of 40 items and is often considered rather heavy to submit. However, it has recently been simplified and the HOOS-12 (HOOS score with 12 items) has been developed and validated. These two scores are useful in current clinical practice but they are only validated in English.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date March 2023
Est. primary completion date September 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult patient (age greater than or equal to 18 years old), - Patient with coxofemoral pathology, - Patient having been informed of the research, - Patient agreeing to participate in the study. Exclusion Criteria: - Minor patient, - Pregnant woman, - Patient out of state to agree to participate in the study, - Patient unable to answer a self-assessment questionnaire, - Patient under justice, guardianship or curatorship, - Patient who refused to participate in the study.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Self-assessment questionnaires
120 patients with coxofemoral pathologies will pass the SUSHI-score and the HOOS-12 score questionnaires. The HAGOS (Hip and Groin Score) questionnaire will be also passed by the subject, for the convergent validity.

Locations

Country Name City State
France Hôpital Lariboisière - AP-HP Paris
France Centre Hospitalier Privé Saint-Grégoire Saint-Grégoire
Martinique CHU of Martinique Fort-de-France

Sponsors (3)

Lead Sponsor Collaborator
University Hospital Center of Martinique Lariboisière Hospital, Saint-Gregoire Private Hospital Center

Countries where clinical trial is conducted

France,  Martinique, 

Outcome

Type Measure Description Time frame Safety issue
Primary Transcultural validation of the SUSHI-score and HOOS-12 score questionnaire It will be a question of obtaining a version translated into French. The translated version tested on a small group of patients (15) will be submitted to the author of the original version of the tool, along with a report highlighting and explaining all the modifications and difficulties noted by a group of experts. 1 month
Primary Psychometric validation of the SUSHI-score and HOOS-12 score questionnaire Questionnaires will be passed by 120 subjects. Following parameters will be measured: feasibility and acceptability, validity, reliability, and sensitivity to change. 12 months